This process transforms fat-soluble toxins into water-soluble compounds that can be eliminated through bile or urine
Ario S, Aguilar-Bravo B, Coll M, Lee WY, Peiseler M, Cantallops-Vil P, Sererols-Vias L, Martnez-Garca de la Torre RA, Martnez-Snchez C, Pedragosa J, et al
Clinical trials show impressive results: tirzepatide reduced the apnea-hypopnea index (AHI) by up to 63% approximately 30 fewer breathing interruptions per hour 33
These fractional draws are trickier and benefit from a syringe with half-unit markings
Therefore, butyrate has become an attractive drug target for T2D, and treatment strategies have been devised to increase its intestinal levels, for example by supplementation of butyrate-producing bacteria and dietary fiber, or through fecal microbiota transplant (FMT)